Global Hormone Replacement Therapy Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 69

Global Hormone Replacement Therapy Market 2015-2019

Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. The expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy

  • Estrogen replacement therapy
  • Growth hormone replacement therapy

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration

  • Oral
  • Parenteral
  • Transdermal

The oral route of administration is a sub-division of enteral administration and is regarded as one of the safest and most preferred routes of drug administration. Some of the drug that are administered orally are Premarin and Estrace.

Competitive landscape and key vendors

The global hormone replacement therapy market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.

Key vendors in this market are –

  • F. Hoffmann-La Roche
  • Merck Serono
  • Novartis
  • Novo Nordisk
  • Pfizer

Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, and Therapeutics MD.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global hormone replacement therapy market?
  • What are the key market trends impacting the growth of the global hormone replacement therapy market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hormone replacement therapy market?
  • What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global hormone replacement therapy market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Biocodex – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an antidiarrheal yeast based probiotic, cough syrup, vitamins, and calcium supplements. The company has partnership with universities and research organizations to advance its research. Biocodex offer its products through wholly owned subsidiaries and distributors in North America, South America, Europe, Asia Pacific and Africa. The company has subsidiaries in Mexico, Canada, Belgium, Russia, the US, Morocco, and Turkey. Biocodex is headquartered in Paris, France. Biocodex - Pharmaceuticals ......
$250

Neurimmune Holding AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company's pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a focus on neurodegenerative disorders. It provides treatment and prevention of human disorders with unmet medical needs. Neurimmune by utilizing its reverse translational medicine technology platform develops human antibodies as therapeutics. The company's human antibodies are used as drug candidates in the treatment of diseases such as Alzheimer's disease, Parkinson's disease and other central nervous system disorders, tauopathies and amyotrophic lateral sclerosis. It operates through research......
$250

Immunocore Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Immunocore Ltd (Immunocore) is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor (TCR) technology. Its products under development include IMCgp100, an ImmTAC reagent used to treat patients with advanced cutaneous and uveal melanomas. The company has collaboration with various pharmaceutical companies, to develop its product candidates for the treatment of metastatic cutaneous melanoma; cancer; and other indications. Immunocore is headquartered in Abingdon, the UK. Immunocore Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company......
$250

Institut Pasteur – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology and chemistry, and virology, among others. It provides health services through its medical centers having vaccination center and outpatient department. Institut Pasteur offers educational services including Institut Pasteur courses, international network courses and doctoral programs. The institute partners with research institutes, private foundations, international organizations, universities academic organizations, associations, and bilateral and multilateral initiatives. Institut Pasteur is......
$250

China National Pharmaceutical Group Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary China National Pharmaceutical Group Corp (Sinopharm) is a provider of medical and healthcare services. Its core businesses include the distribution, retailing, research and manufacture of healthcare related products. Its product portfolio includes EPI vaccines; biopharmaceutical products; anaesthetics and psychotropics; anti-infective, anti-tumor, cardiovascular and respiratory system drugs; and medicinal herbs. Its business activities include manufacturing and R&D, pharmaceutical logistics and distribution, pharmacy retail chain, anaesthetic distribution, cold-chain distribution for biological products and medical equipment, and distribution of consumable materials, modern and traditional Chinese medicines, besides medical scientific research, engineering design and pharmaceuti......
$250

LI-COR Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnology, plant biology, drug discovery and environmental research. LCB's products include genomics reagents, western blot reagents, protease assay reagents, other optical imaging reagents, pearl cam software and protein gel combs. The company's products find application in gas analysis, eddy covariance, photosynthesis, soil gas flux, light measurement, and others. It distributes its products through distributions centers in Africa, Asia, Europe, and North and Central America. LCB is headquartered ......
$250

National Institute of Agricultural Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various collaborative projects and exchanges with the scientific community in Europe, America, Asia and Africa. INRA also conducts research in animal genetics, plant breeding and genetics, applied mathematics and informatics, microbiology and food chain, and social sciences. The institute partners with scientific research institutes, universities, and agronomy and veterinary schools. INRA headquartered in Paris, France. National Institute of Agricultural Research - Pharmaceuticals & Healthcare - Dea......
$250

Kezar Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company's development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune diseases and inflammatory disorders. Kezar's program concentrates on small molecule modulators of the protein secretion to develop therapies in oncology and autoimmune diseases. The company operates in the areas of protein degradation and protein secretion. It also provides process of targeted protein destruction, cellular physiology including proliferation, cytokine production, antigen presentation, and gene activation. Kezar is headquartered in South San Francisco, California, the US. Kez......
$250

Microbion Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company which develops therapeutic products. The company develops products for the treatment of antibiotic-resistant infections and control of microbial biofilms. It develops environmentally responsible solutions to prevent microbial biofilms and the associated biofouling and biocorrosion produced in a various industrial processes. Microbion develops products using its bismuth-thiol platform technology. The company's therapeutic pipeline includes BT compounds for the treatment of chronic and acute wound infections and post-surgical orthopedic infections. It also offers antimicrobial and antibiofilm therapeutics and medical device coating solutions. The company serves healthcare industries. Microbion is headquartere......
$250

iDD biotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary iDD biotech SAS (iDD biotech) is a healthcare products provider that discovers and develops differentiated therapeutic antibodies. The company's products comprise pre-clinical stage therapeutic monoclonal antibodies and active drug discovery programs. It develops therapies for the treatment of cancer, autoimmune diseases, inflammation and other central nervous system diseases. iDD biotech harnesses its antibody biology expertise to develop MAb types which include Fc optimized using its afucosylated MAb platform; antibody-drug-conjugates; and multivalent antibodies. The company partners with research institutes and biotechnology companies for clinical development. iDD biotech is headquartered in Lyon, France. iDD biotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances......
$250